Advanced Biomed Inc Cash and Restricted Cash
Advanced Biomed Inc (ADVB) had Cash and Restricted Cash of $2.60 million as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-05-15
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.60M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.60M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.66M.
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.87M; Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed $2.90M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-03-31 | $2.60M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $2.60M 10-Q · filed 2026-02-13 | |
| 2025-09-30 | $2.66M 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $2.87M 10-Q · filed 2026-05-15 | $2.90M 10-K · filed 2025-10-08 |
| 2025-03-31 | $3.18M 10-Q · filed 2026-05-15 | $5.18M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $2.65M 10-Q · filed 2026-02-13 | $2.66M 10-Q · filed 2025-04-15 |
| 2024-09-30 | $2.65M 10-Q · filed 2025-11-19 | |
| 2024-06-30 | $2.61M 10-Q · filed 2025-11-19 | |
| 2024-03-31 | $2.66M 10-Q · filed 2025-05-15 | |
| 2023-12-31 | $2.78M 10-Q · filed 2025-04-15 | |
| 2023-06-30 | $2.62M 10-K · filed 2025-10-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |